MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) and its transac

NEW YORK, July 14, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

Cogent's bezuclastinib showed strong efficacy in a non-advanced SM trial, with a planned FDA sub

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr.,

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde &

-- Breadth of presentations, including one oral and two flash talks, showcase Blueprint Medicines' l

Byron Allen dials out, Salesforce logs in. Here are the various deal announcements of the past week

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

Jared Holz, Mizuho health care equity strategist, joins 'The Exchange' to discuss the impact of tari

SNY's $9.5 billion deal to acquire BPMC boosts its immunology pipeline and adds fast-growing Ayvakit

SAN DIEGO, June 02, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP has launched an investigation into

MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating Blueprint (Nasdaq: BPMC) for possible br

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether t

The deal announced Monday is Sanofi's third of the year so far.

The deal includes a drug approved in the U.S. and the EU for systemic mastocytosis, a rare immunolog

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding

Sanofi to acquire Blueprint Medicines, expanding portfolio in rare immunological disease and adding

NEW YORK--(BUSINESS WIRE)-- #AI--VantAI, a leader in generative AI and proximity-based therapeutics,

BMPC's first-quarter earnings and sales miss estimates. However, shares rally on raised Ayvakit sale

Blueprint Medicines Corporation (NASDAQ:BPMC ) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM

Blueprint Medicines (BPMC) came out with a quarterly loss of $0.74 per share versus the Zacks Consen

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

Companies Reporting Before The Bell • Cognex (NASDAQ:CGNX) is estimated to report quarterly earning

Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company p

Gainers

U.S. stocks traded lower, with the Nasdaq Composite falling more than 90 points on Thursday. Here ar

Companies Reporting Before The Bell • TotalEnergies (NYSE:TTE) is likely to report quarterly earnin

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimat

We performed a screening of mid-cap ETFs - defined as having Assets Under Management (AUM) between $

Gainers Sono Group N.V. (NYSE: SEV) shares surged 152.7% to $0.4367. Sono Group applied to Insolv

U.S. stocks traded mixed, with the Dow Jones dropping around 100 points on Monday. Here are some big

U.S. stocks traded mixed this morning, with Dow Jones dropping around 20 points on Monday. Followin

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a

  On Friday, 135 companies reached new 52-week lows.